Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BBOX1 | O75936 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 3/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.32 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.32 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.32 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.32 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.32 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2838258 | 0.84 | BBOX1 (0.39) | BBOX1KDM4ELMNAKMT2ACYP3A4 | |
| SCHEMBL13276399 | 0.81 | BBOX1 (0.40) | BBOX1KDM4ELMNAKMT2ACYP3A4 | |
| Thiocyanic Acid SCHEMBL613342 | 0.81 | BBOX1 (0.42) | BBOX1KDM4ELMNAKMT2ACYP3A4 | |
| Cyanamide SCHEMBL666990 | 0.81 | BBOX1 (0.42) | BBOX1KDM4ELMNAKMT2ACYP3A4 | |
| SCHEMBL3622275 | 0.81 | BBOX1 (0.42) | BBOX1KDM4ELMNAKMT2ACYP3A4 | |
| SCHEMBL34829 | 0.80 | BBOX1 (0.52) | BBOX1KDM4ELMNAKMT2ACYP3A4 | |
| SCHEMBL2146700 | 0.80 | BBOX1 (0.39) | BBOX1KDM4ELMNAKMT2ACYP3A4 | |
| Cyanamide SCHEMBL206467 | 0.79 | BBOX1 (0.41) | BBOX1KDM4ELMNAKMT2ACYP3A4 | |
| SCHEMBL4938223 | 0.79 | BBOX1 (0.41) | BBOX1KDM4ELMNAKMT2ACYP3A4 | |
| SCHEMBL30331071 | 0.78 | BBOX1 (0.47) | BBOX1KDM4ELMNAKMT2ACYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8829201-B2 | Electrolyte Formulations | MERCK PATENT GMBH (DE) | 2014-09-09 | — | — | US | disclosed |
| US-20120318360-A1 | Electrolyte Formulations | MERCK PATENT GMBH (DE) | 2012-12-20 | — | — | US | disclosed |
| WO-2011085964-A1 | ELECTROLYTE FORMULATIONS | MERCK PATENT GMBH (DE) | 2011-07-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120318360-A1 | Electrolyte Formulations | NHERF1, HCN4, DDT | BBOX1 3194/4885KDM4E 1254/4885LMNA 4315/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.